Low ferritin with normal hemoglobin
Clinical review pending
Iron deficiency can develop before anemia. Understand symptoms, causes, ferritin thresholds, treatment evidence, and follow-up when hemoglobin is still normal.

Reading ferritin and hemoglobin together
Ferritin, hemoglobin, transferrin saturation, and sometimes an inflammatory marker such as CRP provide complementary information about iron status.
What does this result mean?
Low ferritin with normal hemoglobin indicates iron deficiency without anemia, also called nonanemic iron deficiency. Ferritin is a protein that stores iron inside cells. A low blood level indicates depleted reserves, even while hemoglobin remains above the anemia threshold. The current Merck Manual uses hemoglobin below 13 g/dL for adult men and below 12 g/dL for adult women; the appropriate threshold also depends on factors such as age and pregnancy. Ferritin overview Hemoglobin overview Ferritin testing Anemia assessment
Iron-deficiency anemia is a later stage, when hemoglobin also falls. The American Society of Hematology’s 2026 diagnostic guideline emphasizes identifying iron deficiency whether or not anemia is present. Low stores can therefore matter before a hemoglobin result becomes abnormal; the relative frequency of nonanemic deficiency and iron-deficiency anemia varies between populations. ASH guideline ASH patient information
Why symptoms can appear before anemia
Iron deficiency develops in stages, and symptoms can begin before hemoglobin falls. First, bone marrow iron stores shrink while hemoglobin and serum iron may remain stable. Next, the supply available to make red blood cells becomes inadequate. Transferrin saturation, the proportion of iron-binding sites on transferrin occupied by iron, falls while hemoglobin may still be within range. If the shortage continues, depleted stores can progress to anemia. Stages of deficiency Serum iron NIH iron fact sheet Clinical review
In trials involving iron-deficient adults without anemia, iron treatment reduced self-reported fatigue. The pooled analysis did not find corresponding improvements in objective physical performance. Fatigue is one possible sign of depleted stores, but it is not specific to iron deficiency. Systematic review
Which symptoms are possible?
Nonanemic iron deficiency can cause nonspecific symptoms despite a normal hemoglobin result. Some people have no symptoms, while others notice the following. Clinical review
-
Fatigue: persistent exhaustion.
-
Poor concentration: difficulty focusing, sometimes accompanied by irritability.
-
Restless legs: an urge to move the legs, often at night. Restless legs overview Clinical review
-
Pica: cravings to eat nonfood substances.
-
Exercise intolerance: tiring quickly during physical effort.
-
Lightheadedness: sometimes alongside cold intolerance or poor sleep. Symptom study
-
Hair loss: new or increased shedding. The cited study found an association, which does not establish iron deficiency as the cause of every case. Cross-sectional study
Many conditions produce these symptoms. Blood results and a clinical assessment help determine whether iron deficiency contributes, rather than assuming every unexplained symptom comes from low ferritin. Clinical review Low-ferritin treatment overview
What can cause it?
Low ferritin with normal hemoglobin develops when iron losses or requirements exceed the amount absorbed. The main causes can be grouped by how they deplete the body’s reserves. Clinical review
| Cause | Examples | People commonly affected |
|---|---|---|
| Blood loss | Heavy menstrual bleeding, gastrointestinal bleeding | People with heavy periods; in one cited study of young women with heavy menstrual bleeding, more than half had depleted stores. Gastrointestinal blood loss is an important consideration in men and postmenopausal women. |
| Increased requirements | Pregnancy, intensive endurance training | Pregnant people and female athletes; the cited athlete review describes iron deficiency in up to 60% of female athletes, with prevalence varying by group and definition. |
| Low intake or lower dietary bioavailability | An iron-poor diet or poorly planned vegetarian diet | NIH dietary iron recommendations are 1.8 times higher for vegetarians because nonheme iron is less readily absorbed; this does not mean every vegetarian is deficient. |
| Impaired intestinal absorption | Celiac disease, inflammatory bowel disease, atrophic gastritis, bariatric surgery | People with relevant digestive conditions or a history of stomach surgery. |
| Medications | Long-term acid suppression, regular NSAID painkiller use | In the cited observational study, at least two years of acid-suppressing medication use was associated with a higher risk of iron deficiency. |
Blood-loss overview Gastroenterology guideline Female-athlete review NIH iron recommendations Celiac disease overview IBD overview Acid-suppression study
The overall risk of significant gastrointestinal disease, particularly cancer, is lower with iron deficiency without anemia than with iron-deficiency anemia. That does not eliminate the need to investigate a cause. The threshold for gastrointestinal investigation is lower in men, postmenopausal women, and people with digestive symptoms or a relevant family history. Gastroenterology guideline
How is iron deficiency confirmed?
Ferritin is a central measure of iron stores. Serum iron and total iron-binding capacity, or TIBC, help calculate transferrin saturation and complete the picture. A ferritin level around or below 30 ng/mL commonly supports iron deficiency without inflammation. The 2026 ASH guidance suggests a threshold of ≤30 ng/mL for adults, including menstruating and pregnant people, and allows ≤50 ng/mL in selected higher-risk situations, including heavy menstrual bleeding. Inflammation calls for interpreting ferritin alongside transferrin saturation; saturation below 20% can support the diagnosis in that context. These are clinical decision thresholds, not self-treatment targets. NIH iron fact sheet Ferritin testing Clinical review ASH patient information ASH 2026 recommendations
Inflammation can raise ferritin and hide iron deficiency. A meta-analysis found an overall increase of about 30%, with substantial differences between inflammatory stages and groups. That figure is not a fixed correction factor for an individual’s blood result. An inflammatory marker such as CRP or hsCRP can help with interpretation. Inflammation meta-analysis hsCRP overview
A laboratory reference interval describes results in a reference population; it is not necessarily the same as a diagnostic threshold. A commonly listed female range starts at 15 ng/mL, but a US population study estimated a threshold near 25 ng/mL for iron-restricted red-cell production in nonpregnant women. That was a population-level estimate, not a precise switch point for every individual. Confirmed deficiency should lead to assessment of its cause and suitable treatment. Laboratory ranges NHANES study
Treatment and follow-up
Treatment involves finding the cause, replenishing stores, and checking progress. Evidence for treating iron deficiency without anemia is limited and depends on the symptoms and population studied. In a randomized trial of fatigued, nonanemic menstruating women with ferritin below 50 ng/mL, the mean fatigue score fell by 47.7% after 12 weeks of iron, compared with 28.8% on placebo. These percentages describe changes in a symptom score, not the proportion of women cured. Treatment review Randomized trial
-
Identify the cause. Investigate blood loss, increased requirements, or impaired absorption and address them where possible. Clinical review
-
Replenish iron stores. Oral iron is often used first. Alternate-day dosing may be considered; the cited absorption trials found better absorption on that schedule in iron-depleted women, rather than proving a universally better clinical outcome. Intravenous iron may be appropriate when oral treatment is not tolerated or absorbed, among other indications. The choice belongs with the treating clinician. Absorption trials
-
Recheck iron status. The cited nonanemic-deficiency review suggests repeating ferritin and related tests after 60–90 days of oral iron. Timing and test preparation should be individualized, rather than treated as a rule for every situation. Follow-up review
Replenishing stores can take months. Follow-up ferritin and hemoglobin, with an inflammatory marker where needed, help assess the response. Iron-deficiency overview
Why hemoglobin alone is not enough
Normal hemoglobin does not rule out depleted iron stores. Ferritin, serum iron, transferrin saturation, and TIBC contribute different information; inflammatory markers can help interpret the result when needed. The aim is to understand the pattern and its cause, not to judge iron status from one number in isolation. Transferrin saturation TIBC
Sources
-
Cleveland Clinic (2025). Ferritin test: levels and test results. Cleveland Clinic Health Library. Last updated August 11, 2025. Quelle
-
Gerber GF (2026). Evaluation of Anemia. Merck Manual Professional Version. Last updated October 2026. Quelle
-
Powers JM, Lim MY, Achebe MO, et al (2026). American Society of Hematology 2026 guidelines for diagnosis of iron deficiency. Blood Advances. Published online August 24, 2026. https://doi.org/10.1182/bloodadvances.2025015950 Quelle
-
American Society of Hematology. Iron-deficiency anemia. Hematology.org. Accessed October 17, 2026. Quelle
-
Gerber GF (2025). Iron deficiency anemia. Merck Manual Professional Version. Last updated April 2025. Quelle
-
Office of Dietary Supplements (2025). Iron: fact sheet for health professionals. National Institutes of Health. Updated September 4, 2025. Quelle
-
Auerbach M, DeLoughery TG, Tirnauer JS (2025). Iron Deficiency in Adults: A Review. JAMA, 333(20), 1813–1823. https://doi.org/10.1001/jama.2025.0452 Quelle
-
Houston BL, Hurrie D, Graham J, et al (2018). Efficacy of iron supplementation on fatigue and physical capacity in non-anaemic iron-deficient adults: a systematic review of randomised controlled trials. BMJ Open, 8(4), e019240. https://doi.org/10.1136/bmjopen-2017-019240 Quelle
-
Balendran S, Forsyth C (2021). Non-anaemic iron deficiency. Australian Prescriber, 44(6), 193–196. https://doi.org/10.18773/austprescr.2021.052 Quelle
-
Snook J, Bhala N, Beales ILP, et al (2021). British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults. Gut, 70(11), 2030–2051. https://doi.org/10.1136/gutjnl-2021-325210 Quelle
-
Pengelly M, Pumpa K, Pyne DB, Etxebarria N (2025). Iron deficiency, supplementation, and sports performance in female athletes: A systematic review. Journal of Sport and Health Science, 14, 101009. https://doi.org/10.1016/j.jshs.2024.101009 Quelle
-
Lam JR, Schneider JL, Quesenberry CP, Corley DA (2017). Proton Pump Inhibitor and Histamine-2 Receptor Antagonist Use and Iron Deficiency. Gastroenterology, 152(4), 821–829.e1. https://doi.org/10.1053/j.gastro.2016.11.023 Quelle
-
Thurnham DI, McCabe LD, Haldar S, Wieringa FT, Northrop-Clewes CA, McCabe GP (2010). Adjusting plasma ferritin concentrations to remove the effects of subclinical inflammation in the assessment of iron deficiency: a meta-analysis. American Journal of Clinical Nutrition, 92(3), 546–555. https://doi.org/10.3945/ajcn.2010.29284 Quelle
-
Mei Z, Addo OY, Jefferds ME, Sharma AJ, Flores-Ayala RC, Brittenham GM (2021). Physiologically based serum ferritin thresholds for iron deficiency in children and non-pregnant women: a US National Health and Nutrition Examination Surveys (NHANES) serial cross-sectional study. Lancet Haematology, 8(8), e572–e582. https://doi.org/10.1016/S2352-3026(21)00168-X Quelle
-
Vaucher P, Druais PL, Waldvogel S, Favrat B (2012). Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial. CMAJ, 184(11), 1247–1254. https://doi.org/10.1503/cmaj.110950 Quelle
-
Stoffel NU, Cercamondi CI, Brittenham G, et al (2017). Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematology, 4(11), e524–e533. https://doi.org/10.1016/S2352-3026(17)30182-5 Quelle
-
Beatrix J, Piales C, Berland P, Marchiset E, Gerbaud L, Ruivard M (2022). Non-anemic iron deficiency: correlations between symptoms and iron status parameters. European Journal of Clinical Nutrition, 76(6), 835–840. https://doi.org/10.1038/s41430-021-01047-5 Quelle
-
Özbilen M, Kaya Y (2025). Beyond anemia: a comprehensive analysis of iron deficiency symptoms in women and their correlation with biomarkers. BMC Women’s Health, 25(1), 376. https://doi.org/10.1186/s12905-025-03906-w Quelle
-
American Society of Hematology (2026). ASH 2026 Guidelines on Diagnosis of Iron Deficiency: Visual Summary of Recommendations. ASH visual summary